Twelve months after revaccination, antibody levels declined but remained significantly higher than baseline in patients with CLL.

Pfizer's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in ...

The CDC’s ACIP updated guidance on pneumococcal vaccination, recommending a single dose of PCV for all adults aged 50 years and older.

At the north eastern tip of Kasungu District, near the border with Mzimba, sits Manjondo Village, telephonically disconnected ...

Early protection for young and very young children against pneumococcus is not only about protecting the children themselves but also about limiting transmission, contributing to the protection of the ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

Babies treated with antibiotics in the first few weeks of their life are likely to show weaker immune responses to essential ...

The PCV13 vaccine makes it easier for the immune system to attack S. pneumoniae and produce antibodies by linking the polysaccharide capsule layer to proteins. Exposure to neonatal antibiotics ...

The FDA has approved a new pneumococcal vaccine from Merck & Co, just over a month after Pfizer got a green light for a new version of its market leading Prevnar shot. Merck's Vaxneuvance ...

While antibiotics given in the first week of life reduce vaccine responses at 15 months, probiotics might counteract these ...